Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Operating Leases (2019 - 2025)

Nephros has reported Operating Leases over the past 7 years, most recently at $672000.0 for Q4 2025.

  • Quarterly results put Operating Leases at $672000.0 for Q4 2025, down 36.78% from a year ago — trailing twelve months through Dec 2025 was $672000.0 (down 36.78% YoY), and the annual figure for FY2025 was $672000.0, down 36.78%.
  • Operating Leases for Q4 2025 was $672000.0 at Nephros, down from $774000.0 in the prior quarter.
  • Over the last five years, Operating Leases for NEPH hit a ceiling of $1.4 million in Q4 2023 and a floor of $201000.0 in Q3 2022.
  • Median Operating Leases over the past 5 years was $705000.0 (2022), compared with a mean of $764647.1.
  • Biggest five-year swings in Operating Leases: tumbled 55.2% in 2021 and later surged 146.06% in 2024.
  • Nephros' Operating Leases stood at $340000.0 in 2021, then surged by 107.35% to $705000.0 in 2022, then skyrocketed by 97.16% to $1.4 million in 2023, then decreased by 23.53% to $1.1 million in 2024, then tumbled by 36.78% to $672000.0 in 2025.
  • The last three reported values for Operating Leases were $672000.0 (Q4 2025), $774000.0 (Q3 2025), and $872000.0 (Q2 2025) per Business Quant data.